Skip to main content
Clinical Trials/NCT02756715
NCT02756715CompletedNot Applicable

The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery

Konkuk University Medical Center1 site in 1 country80 target enrollmentStarted: May 30, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
Syndecan-1

Study Overview

Brief Summary

Ischeic reperfusion injury lead to a cellular dyfunction and increase in soluble glycocalyx of blood flow. syndecan-1 was a marker of glycocalyx.

The purpose of this study is to prove the variation of level of serum syndecan-1 between preoperative and postoperative period.

Detailed Description

The patients were allocated randomly to receive propofol or desflurane. Also, a total of 6ml of blood sample was obtained for total 6 times in consecutive order.

  1. Preoperation (immediate before anesthesia induction)
  2. Immediate before tourniquet off
  3. 5 min after tourniquet off
  4. PACU
  5. postoperative 6 hours
  6. postoperative 24 hours

Serum in blood will be obtained and level of serum cytokine will be evaluated by enzyme-linked immunosorbent assay

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Single (Investigator)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients who was planned to undergo knee surgery.

Exclusion Criteria

  • age < 20 years old
  • history of previous cancer
  • history of previous peripheral vascular disease
  • Emergency surgery

Arms & Interventions

propofol group

Active Comparator

The patient who anesthetized by using propofol.

Intervention: propofol group (Drug)

Desflurane group

Active Comparator

The patient who anesthetized by using sevoflurane.

Intervention: Desflurane group (Drug)

Outcomes

Primary Outcomes

Syndecan-1

Time Frame: Preoperative time, Immediate before tourniquet off,5 min after tourniquet off,PACU, postoperation after 6hours, postoperation after 24hours

change of level of syndecan-1 (scores range from 0 to 100)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Seong-Hyop Kim

Associate Professor

Konkuk University Medical Center

Study Sites (1)

Loading locations...

Similar Trials